HOOPER ANTHONY C

SEC source: 0001127602-15-015473 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,334

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,943 RSUs which vest on 4/27/2016; 5,010 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 4,597 RSUs which vest in two equal installments of 1,517 on 1/30/2017 and 1/30/2018 and one installment of 1,563 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 520 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-15-012982 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,909

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 5,010 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 4,597 RSUs which vest in two equal installments of 1,517 on 1/30/2017 and 1/30/2018 and one installment of 1,563 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 680 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-15-011303 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,148

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 5,010 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 4,597 RSUs which vest in two equal installments of 1,517 on 1/30/2017 and 1/30/2018 and one installment of 1,563 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 573 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-15-010545 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 222,688

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 5,010 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 4,597 RSUs which vest in two equal installments of 1,517 on 1/30/2017 and 1/30/2018 and one installment of 1,563 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 573 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-15-009819 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,334

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 5,010 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 4,597 RSUs which vest in two equal installments of 1,517 on 1/30/2017 and 1/30/2018 and one installment of 1,563 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 573 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-15-004133 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,549

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/30/2017, 1/30/2018 and 1/30/2019, respectively.

F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 7,239 RSUs which vest in one installment on 3/2/2015; 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 5,101 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively; and 4,597 RSUs which vest in two equal installments of 1,517 on 1/30/2017 and 1/30/2018 and one installment of 1,563 on 1/30/2019. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 573 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-15-003487 · form4.xml · nonDerivative · entry 2

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,952

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 7,239 RSUs which vest in one installment on 3/2/2015; 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 5,101 RSUs which vest in one installment of 2,467 on 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 573 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-15-003487 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,987

SEC source: 0001127602-14-015508 · form4.xml · nonDerivative · entry 2

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,664

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 7,239 RSUs which vest in one installment on 3/2/2015; 5,799 RSUs which vest in two installments of 2,856 and 2,943 on 4/27/2015 and 4/27/2016, respectively; 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 417 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-14-015508 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,720

SEC source: 0001127602-14-011619 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,210

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 7,239 RSUs which vest in one installment on 3/2/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 523 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-14-010752 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,642

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 7,239 RSUs which vest in one installment on 3/2/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 415 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-14-009977 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,865

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 7,239 RSUs which vest in one installment on 3/2/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 415 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-14-004381 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,402

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/31/2016, 1/31/2017 and 1/31/2018, respectively.

F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 16,699 RSUs which fully vest on 3/2/2014; 7,239 RSUs which vest in one installment on 3/2/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017; and 5,044 RSUs which vest in three installments of 1,664, 1,665 and 1,715 on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 415 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-13-010825 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,060

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,009 RSUs which fully vest on 3/2/2014; 14,929 RSUs which vest in one installment of 7,690 on 3/2/2014 and one installment of 7,239 on 3/2/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-13-010160 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,600

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,009 RSUs which fully vest on 3/2/2014; 14,929 RSUs which vest in one installment of 7,690 on 3/2/2014 and one installment of 7,239 on 3/2/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-13-009086 · form4.xml · nonDerivative · entry 2

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,823

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,009 RSUs which fully vest on 3/2/2014; 14,929 RSUs which vest in one installment of 7,690 on 3/2/2014 and one installment of 7,239 on 3/2/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-13-009086 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,932

SEC source: 0001127602-13-003259 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,821

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/28/2015, 1/28/2016 and 1/28/2017, respectively.

F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 17,753 RSUs which vest in one installment of 8,744 on 3/2/2013 and one installment of 9,009 on 3/2/2014; 22,619 RSUs which vest in two equal installments of 7,690 each on 3/2/2013 and 3/2/2014 and one installment of 7,239 on 3/2/2015; 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 7,477 RSUs which vest in two equal installments of 2,467 each on 1/28/2015 and 1/28/2016 and one installment of 2,543 on 1/28/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3 · balance_after: These shares include 117 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

SEC source: 0001127602-12-015253 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,227

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 17,753 RSUs which vest in one installment of 8,744 on 3/2/2013 and one installment of 9,009 on 3/2/2014; 22,619 RSUs which vest in two equal annual installments of 7,690 each on 3/2/2013 and 3/2/2014 and one installment of 7,239 on 3/2/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001127602-12-009595 · form4.xml · nonDerivative · entry 2

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,573

F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 17,753 RSUs which vest in one installment of 8,744 on 3/2/2013 and one installment of 9,009 on 3/2/2014; and 22,619 RSUs which vest in two equal annual installments of 7,690 each on 3/2/2013 and 3/2/2014 and one installment of 7,239 on 3/2/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001127602-12-009595 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,655

SEC source: 0001127602-12-003808 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,735

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 3/2/2012, 3/2/2013 and 3/2/2014, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 22,619 which fully vest on 3/2/2012; 26,497 RSUs which vest in two equal installments of 8,744 each on 3/2/2012 and 3/2/2013 and one installment of 9,009 on 3/2/2014; 22,619 RSUs which vest in two equal installments of 7,690 each on 3/2/2013 and 3/2/2014 and one installment of 7,239 on 3/2/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001127602-11-027872 · form4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · EVP, Global Commercial Ops.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,238

F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Company's 2009 Equity Incentive Plan and vest on the following schedule: 22,619 RSUs vest on 3/2/2012; 15,380 RSUs vest in two equal annual installments of 7,690 on 3/2/2013 and 3/2/2014; and 7,239 RSUs vest on 3/2/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

SEC source: 0001225208-11-014675 · doc4.xml · derivative · entry 10

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 68,000 shares

Expires 2013-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Currently exercisable.

SEC source: 0001225208-11-014675 · doc4.xml · derivative · entry 9

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 78,750 shares

Expires 2016-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Currently exercisable.

SEC source: 0001225208-11-014675 · doc4.xml · derivative · entry 8

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,495

Underlying: Common Stock, $0.10 par value · 125,000 shares

Expires 2018-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Twenty-five percent of the stock option award vests on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0001225208-11-014675 · doc4.xml · derivative · entry 7

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,634

Underlying: Common Stock, $0.10 par value · 110,000 shares

Expires 2019-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Twenty-five percent of the stock option award vests on each of the first, second, third and fourth anniversaries of the grant date.

SEC source: 0001225208-11-014675 · doc4.xml · nonDerivative · entry 4

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 203,170

F3 · shares: Shares withheld for payment of exercise price upon exercise of stock options.

F1 · price: This transaction was executed in multiple trades from $28.7500 to $28.8550. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-11-014675 · doc4.xml · nonDerivative · entry 3

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482,937

F2 · shares: Shares withheld for payment of taxes and fees upon exercise of stock options.

F1 · price: This transaction was executed in multiple trades from $28.7500 to $28.8550. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-11-014675 · doc4.xml · nonDerivative · entry 2

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 530,806

F1 · price: This transaction was executed in multiple trades from $28.7500 to $28.8550. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-11-014675 · doc4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 544,178

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-11-009171 · doc4.xml · nonDerivative · entry 5

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,428

F4 · shares: Shares withheld for payment of taxes upon vesting of restricted stock.

SEC source: 0001225208-11-009171 · doc4.xml · derivative · entry 9

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,434

Underlying: Common Stock, $0.10 par value · 8,717 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F7 · derivative.exercise_date: Shares consist of restricted stock units with one-third vesting on each of the third, forth, and fifth anniversaries of the grant date.

F7 · derivative.expiration_date: Shares consist of restricted stock units with one-third vesting on each of the third, forth, and fifth anniversaries of the grant date.

SEC source: 0001225208-11-009171 · doc4.xml · nonDerivative · entry 4

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,349

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units.

F2 · balance_after: Includes unvested restricted stock awards.

SEC source: 0001225208-11-009171 · doc4.xml · nonDerivative · entry 3

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,390

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares acquired upon vesting of restricted stock units.

F2 · balance_after: Includes unvested restricted stock awards.

SEC source: 0001225208-11-009171 · doc4.xml · derivative · entry 8

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,718

Underlying: Common Stock, $0.10 par value · 4,359 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting.

F7 · derivative.exercise_date: Shares consist of restricted stock units with one-third vesting on each of the third, forth, and fifth anniversaries of the grant date.

F7 · derivative.expiration_date: Shares consist of restricted stock units with one-third vesting on each of the third, forth, and fifth anniversaries of the grant date.

SEC source: 0001225208-11-009171 · doc4.xml · nonDerivative · entry 2

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,673

F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units.

F2 · balance_after: Includes unvested restricted stock awards.

SEC source: 0001225208-11-009171 · doc4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,694

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares acquired upon vesting of restricted stock units.

F2 · balance_after: Includes unvested restricted stock awards.

SEC source: 0001225208-11-008870 · doc4.xml · derivative · entry 6

HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,307

Underlying: Common Stock, $0.10 par value · 8,921 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock based on the average of the closing share price of the company's common stock on the vesting date and the nine trading days immediately preceding the vesting date.

F7 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor.

F7 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor.

SEC source: 0001225208-11-008870 · doc4.xml · nonDerivative · entry 3

HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,335

F4 · shares: Shares withheld for payment of taxes upon vesting of market share units.

F2 · balance_after: Includes unvested restricted stock awards.

SEC source: 0001225208-11-008870 · doc4.xml · nonDerivative · entry 2

HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,622

F3 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.

F2 · balance_after: Includes unvested restricted stock awards.

SEC source: 0001225208-11-008870 · doc4.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 162,295

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Shares acquired upon vesting of market share units.

F2 · balance_after: Includes unvested restricted stock awards.

SEC source: 0001225208-11-009868 · doc4a.xml · nonDerivative · entry 1

HOOPER ANTHONY C · CIK 0001277244 · SVP ComOps Pres USJap Int

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,335

F1 · shares: This Form 4 is amended to report the correct price for the shares withheld for payment of taxes upon vesting of market share units.

F2 · balance_after: Includes unvested restricted stock awards.

SEC source: 0001225208-11-008703 · doc4.xml · derivative · entry 11

HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,675.78

Underlying: Common Stock, $0.10 par value · 76,455 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011.

F1 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award.

F7 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011.

F7 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011.

SEC source: 0001225208-11-008703 · doc4.xml · derivative · entry 10

HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,130.78

Underlying: Common Stock, $0.10 par value · 1,089.78 shares

Expires not disclosed

F12 · derivative.exercise_price: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013.

F12 · shares: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013.

F12 · derivative.exercise_date: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013.

F12 · derivative.expiration_date: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013.

SEC source: 0001225208-11-008703 · doc4.xml · derivative · entry 9

HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,041

Underlying: Common Stock, $0.10 par value · 19,989 shares

Expires not disclosed

F10 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012.

F11 · shares: Consists of performance shares earned under the 2009-2011 Long-Term Performance Award.

F10 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012.

F10 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012.

SEC source: 0001225208-11-008703 · doc4.xml · derivative · entry 8

HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,052

Underlying: Common Stock, $0.10 par value · 21,327 shares

Expires not disclosed

F8 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

F9 · shares: Consists of performance shares earned under the 2010-2012 Long-Term Performance Award.

F8 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

F8 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

SEC source: 0001225208-11-008703 · doc4.xml · derivative · entry 7

HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,725

Underlying: Common Stock, $0.10 par value · 23,018 shares

Expires not disclosed

F7 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011.

F1 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award.

F7 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011.

F7 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011.

SEC source: 0001225208-11-008703 · doc4.xml · derivative · entry 6

HOOPER ANTHONY C · CIK 0001277244 · SVPComOps PresUSJapInterc

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,228

Underlying: Common Stock, $0.10 par value · 37,544 shares

Expires not disclosed

F5 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock based on the average of the closing share price of the company's common stock on the vesting date and the nine trading days immediately preceding the vesting date.

F6 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor.

F6 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor.